1. A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk. Issue 2 (1st October 2022) Authors: Dicanio, Marco; Giaccherini, Matteo; Clay‐Gilmour, Alyssa; Macauda, Angelica; Sainz, Juan; Machiela, Mitchell J.; Rybicka‐Ramos, Malwina; Norman, Aaron D.; Tyczyńska, Agata; Chanock, Stephen J.; Barington, Torben; Kumar, Shaji K.; Bhatti, Parveen; Cozen, Wendy; Brown, Elizabeth E.; Suska, Anna; H... Journal: International journal of cancer Issue: Volume 152:Issue 2(2023) Page Start: 239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CALR mutations screening should not be studied in splanchnic vein thrombosis. (2nd February 2015) Authors: Castro, Nerea; Rapado, Inmaculada; Ayala, Rosa; Martinez‐Lopez, Joaquin Journal: British journal of haematology Issue: Volume 170:Number 4(2015:Aug.) Page Start: 588 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical applicability and prognostic significance of molecular response assessed by fluorescent‐PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/PETHEMA study. (3rd October 2013) Authors: Martinez‐Lopez, Joaquin; Fernández‐Redondo, Elena; García‐Sánz, Ramón; Montalbán, María Angeles; Martínez‐Sánchez, Pilar; Pavia, Bruno; Mateos, María Victoria; Rosiñol, Laura; Martín, Marisa; Ayala, Rosa; Martínez, Rafael; Blanchard, María Jesus; Alegre, Adrian; Besalduch, Joan; Bargay, Joan; Her... Journal: British journal of haematology Issue: Volume 163:Number 5(2013:Dec.) Page Start: 581 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Do myeloproliferative neoplasms and multiple myeloma share the same genetic susceptibility loci?. Issue 7 (27th October 2020) Authors: Macauda, Angelica; Giaccherini, Matteo; Sainz, Juan; Gemignani, Federica; Sgherza, Nicola; Sánchez‐Maldonado, José Manuel; Gora‐Tybor, Joanna; Martinez‐Lopez, Joaquin; Carreño‐Tarragona, Gonzalo; Jerez, Andrés; Spadano, Raffaele; Gołos, Aleksandra; Jurado, Manuel; Hernández‐Mohedo, Francisca; Maz... Journal: International journal of cancer Issue: Volume 148:Issue 7(2021) Page Start: 1616 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Elotuzumab in combination with thalidomide and low‐dose dexamethasone: a phase 2 single‐arm safety study in patients with relapsed/refractory multiple myeloma. (19th July 2016) Authors: Mateos, María‐Victoria; Granell, Miguel; Oriol, Albert; Martinez‐Lopez, Joaquin; Blade, Joan; Hernandez, Miguel T.; Martín, Jesus; Gironella, Mercedes; Lynch, Mark; Bleickardt, Eric; Paliwal, Prashni; Singhal, Anil; San‐Miguel, Jesus Journal: British journal of haematology Issue: Volume 175:Number 3(2016) Page Start: 448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients. Issue 2 (30th March 2021) Authors: Macauda, Angelica; Piredda, Chiara; Clay‐Gilmour, Alyssa I.; Sainz, Juan; Buda, Gabriele; Markiewicz, Miroslaw; Barington, Torben; Ziv, Elad; Hildebrandt, Michelle A. T.; Belachew, Alem A.; Varkonyi, Judit; Prejzner, Witold; Druzd‐Sitek, Agnieszka; Spinelli, John; Andersen, Niels Frost; Hofmann, ... Journal: International journal of cancer Issue: Volume 149:Issue 2(2021) Page Start: 327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. How do we manufacture clinical‐grade interleukin‐15–stimulated natural killer cell products for cancer treatment?. Issue 6 (14th March 2018) Authors: Fernández, Lucía; Leivas, Alejandra; Valentín, Jaime; Escudero, Adela; Corral, Dolores; de Paz, Raquel; Vela, Maria; Bueno, David; Rodríguez, Rebeca; Torres, Juan Manuel; Díaz‐Almirón, Mariana; López‐Collazo, Eduardo; Martinez‐Lopez, Joaquin; Pérez‐Martínez, Antonio Journal: Transfusion Issue: Volume 58:Issue 6(2018) Page Start: 1340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients. (6th August 2018) Authors: Macauda, Angelica; Castelli, Eleonora; Buda, Gabriele; Pelosini, Matteo; Butrym, Aleksandra; Watek, Marzena; Kruszewski, Marcin; Vangsted, Annette Juul; Rymko, Marcin; Jamroziak, Krzysztof; Abildgaard, Niels; Haastrup, Eva Kannik; Mazur, Grzegorz; Ríos, Rafael; Jurczyszyn, Artur; Zawirska, Daria;... Journal: British journal of haematology Issue: Volume 183:Number 3(2018) Page Start: 375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm. (5th April 2013) Authors: Barrio, Santiago; Gallardo, Miguel; Arenas, Alicia; Ayala, Rosa; Rapado, Inmaculada; Rueda, Daniel; Jimenez, Ana; Albizua, Enriqueta; Burgaleta, Carmen; Gilsanz, Florinda; Martinez‐Lopez, Joaquin Journal: British journal of haematology Issue: Volume 161:Number 5(2013:Jun.) Page Start: 667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis. Issue 1 (4th June 2022) Authors: Dimopoulos, Meletios A.; Moreau, Philippe; Augustson, Bradley; Castro, Nelson; Pika, Tomas; Delimpasi, Sosana; De la Rubia, Javier; Maiolino, Angelo; Reiman, Tony; Martinez‐Lopez, Joaquin; Martin, Thomas; Mikhael, Joseph; Yong, Kwee; Risse, Marie‐Laure; Asset, Gaelle; Marion, Sylvia; Hajek, Roman Journal: American journal of hematology Issue: Volume 98:Issue 1(2023) Page Start: E15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗